News

TearScience® Solution Helps Vision Source Members Better Serve Dry Eye Patients

MORRISVILLE, N.C.─May 20, 2013─TearScience®, a privately held medical device company, today announced an agreement with Vision Source, a network of private practice optometrists that share knowledge and resources to provide the best eye care, to make TearScience’s solution for identifying and treating evaporative dry eye available to its members. Vision Source members are well known for pioneering advanced technology in their eye care practices.

More than 23 million Americans ...

TV Show to Feature LipiFlow, Only U.S. Food and Drug Administration-Cleared Treatment Available for Leading Cause of Dry Eye

MORRISVILLE, N.C.─May 3, 2013─TearScience, a privately held medical device company, today announced that its LipiFlow treatment for evaporative dry eye will be featured on the syndicated television talk show, The Doctors, on May 6, 2013 (check local listings).  The show will air on local affiliates in the U.S. and Canada.  Check www.thedoctorstv.com for show times in each market.

More than 23 million Americans ...

List of Leading Academic Institutions Embracing the TearScience® System Grows

MORRISVILLE, N.C.─April 19, 2013─TearScience®, a privately held medical device company, today announced that Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine is now using the TearScience® LipiView® and LipiFlow® for evaluating and treating evaporative dry eye patients at its Ocular Surface Center in Plantation, Florida. Bascom Palmer Eye Institute is ranked the nation’s number one ophthalmology program in U.S. News & World Report’s annual ...

TearScience® Establishes Center of Excellence to Assist Eye Care Practices with Optimal Implementation of Its System for Assessing and Treating Evaporative Dry Eye

MORRISVILE, N.C.,—March 11, 2013—TearScience®, Inc., a privately-held medical device company, today announced Duke Eye Center of Durham, North Carolina, will become a TearScience® Center of Excellence providing eye care practices with education on implementing the company’s system for assessing and treating evaporative dry eye. As a Center of Excellence, Duke will host eye care ...

Read More →

Funding Positions TearScience to Fully Commercialize its TearScience System as the Standard of Care for the Dry Eye Market

Morrisville, N.C.,—February 25, 2013—TearScience, Inc., a privately held medical device company, today announced that it has secured up to $70 million in funding from HealthCare Royalty Partners to fully implement the company’s commercialization efforts and establish the TearScience system as the “Standard of Care” for evaporative dry eye. TearScience is focused on the worldwide dry eye market ...

Catherine Albou-Ganem, MD Embraces LipiFlow^®as a Safe and Effective Method for Managing Evaporative Dry Eye

MORRISVILLE, N.C. AND PARIS, FRANCE─ February 13, 2013─TearScience_®, a privately held medical device company, today announced that the president of the French Society of Refractive Surgery, Catherine Albou-Ganem, MD, has purchased the TearScience® system for evaluating and treating evaporative dry eye.  Dr Albou-Ganem is the first to implement the TearScience® system in France.

Dry eye disease is a common complaint among patients visiting eye care physicians. ...

LipiView^®Version 2.0 Software Receives US FDA Clearance,  Enhances Physician’s Ability to Define Cause of Dry Eye

Morrisville, N.C.,—January 18, 2013—TearScience^®, Inc., a privately-held medical device company, today announced that the U.S. Food and Drug Administration (FDA) has cleared additional features and broadened the indication for use of the company’s LipiView^® Ocular Surface Interferometer. TearScience^® can now claim LipiView^® measures the absolute thickness of the tear film lipid layer in nanometers.  LipiView^®’s broadened indication for use is a result of ...

TearScience Receives Critical Clinical Endorsements at Joint Meeting of American Academy of Ophthalmology & Asia Pacific Academy of Ophthalmology

MORRISVILLE, N.C.─December 7, 2012─TearScience^®, a privately held medical device company, today announced that momentum from a successful program at the American Academy of Ophthalmology meeting this past November will result in the company reaching a milestone of 100 system installations.  TearScience’s LipiView^® and LipiFlow^® devices for assessing and treating evaporative dry eye were featured at key symposia during ...

MORRISVILLE, N.C. AND MILAN, ITALY─November 26, 2012─TearScience®, a privately held medical device company, today announced that the president of the Italian Society of Ophthalmology, Matteo Piovella, MD, has purchased the TearScience® system for evaluating and treating evaporative dry eye.

Dry eye disease is a frequent patient complaint. Studies show that 86 percent of the millions who suffer with dry eye have evaporative dry eye, which is caused by Meibomian Gland Dysfunction (MGD) and a lipid deficiency of the ...

MORRISVILLE, N.C.─November 19, 2012─TearScience®, a privately held medical device company, today announced that it has been selected as the 2012 winner of the Emerging Company Award from the North Carolina Technology Association (NCTA). Winners were recognized at the annual awards gala on November 8, 2012 at the Sheraton Imperial in Durham, North Carolina. Nearly 800 technology leaders from across the state attended the event.

“We are honored to receive this award,” said Tim Willis, CEO and co-founder ...